APA (7th ed.) Citation

Trefond, L., Drumez, E., Andre, M., Costedoat-Chalumeau, N., Seror, R., Devaux, M., . . . Richez, C. (2021). Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases. Joint Bone Spine, 88(6), N.PAG. https://doi.org/10.1016/j.jbspin.2021.105226

Chicago Style (17th ed.) Citation

Trefond, Ludovic, et al. "Impact of Hydroxychloroquine Used as DMARD on SARS-CoV-2 Tests and Infection Evolution in a Population of 871 Patients with Inflammatory Rheumatic and Musculoskeletal Diseases." Joint Bone Spine 88, no. 6 (2021): N.PAG. https://doi.org/10.1016/j.jbspin.2021.105226.

MLA (9th ed.) Citation

Trefond, Ludovic, et al. "Impact of Hydroxychloroquine Used as DMARD on SARS-CoV-2 Tests and Infection Evolution in a Population of 871 Patients with Inflammatory Rheumatic and Musculoskeletal Diseases." Joint Bone Spine, vol. 88, no. 6, 2021, p. N.PAG, https://doi.org/10.1016/j.jbspin.2021.105226.